Eiger BioPharmaceuticals, Inc. (EIGRQ)
OTCMKTS: EIGRQ · Delayed Price · USD
12.75
+1.20 (10.39%)
Jun 25, 2024, 1:33 PM EDT - Market open

Eiger BioPharmaceuticals Market Cap

Eiger BioPharmaceuticals has a market cap or net worth of $18.88 million as of June 25, 2024. Its market cap has decreased by -52.80% in one year.

Market Cap
18.88M
Enterprise Value
32.87M
1-Year Change
-52.80%
Ranking
n/a
Category
Stock Price
$12.75

Market Cap Chart

Since January 30, 2014, Eiger BioPharmaceuticals's market cap has decreased from $140.60M to $18.88M, a decrease of -86.57%. That is a compound annual growth rate of -17.87%.

History

DateMarket Cap% Change
Apr 10, 20242.60M-7.14%
Apr 9, 20242.80M-9.68%
Apr 8, 20243.10M-8.82%
Apr 5, 20243.40M3.03%
Apr 4, 20243.30M37.50%
Apr 3, 20242.40M26.32%
Apr 2, 20241.90M-9.52%
Apr 1, 20242.10M-71.62%
Mar 28, 20247.40M-
Mar 27, 20247.40M-6.33%
Mar 26, 20247.90M-4.82%
Mar 25, 20248.30M-2.35%
Mar 22, 20248.50M-3.41%
Mar 21, 20248.80M11.39%
Mar 20, 20247.90M11.27%
Mar 19, 20247.10M-6.58%
Mar 18, 20247.60M-
Mar 15, 20247.60M-3.80%
Mar 14, 20247.90M-11.24%
Mar 13, 20248.90M2.30%
Mar 12, 20248.70M-13.00%
Mar 11, 202410.00M-1.96%
Mar 8, 202410.20M-3.77%
Mar 7, 202410.60M4.95%
Mar 6, 202410.10M-1.94%
View and export this data all the way back to 2014. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly 840.04B
Novo Nordisk 629.63B
UnitedHealth Group 444.17B
Johnson & Johnson 357.99B
Merck & Co. 331.09B
AbbVie 300.89B
AstraZeneca 244.57B
Thermo Fisher 215.52B
Market Cap Rankings